Technology: Biotechnology, Health Care, Therapeutics
Headquarters: Cambridge, Massachusetts, United States
Last Funding Date: 2022-09-12
Total Funding: 1170000000.0
Last Funding Type: Post-IPO Equity
Acquisitions Number: 1
Founded Date: 2016-01-01
Investors Number: 12.0
Industry: End-to-End Drug Development
Employee Number: 101-250
Estimated Revenue: $1M to $10M
Funding Status: IPO